Showing results (11-20 of 64) with videos related to
Sort By:
Pageof 7
Molecular Cancer Research : MCR|July 9, 2009
Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivoJan Mueller, Florian C Gaertner, Birgit Blechert, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2005
Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOCFlavio Forrer, Helena Uusijärvi, Daniel Storch, et al.Dental Materials : Official Publication of the Academy of Dental Materials|July 26, 2005
Influence of the application time on the penetration of different dental adhesives and a fissure sealant into artificial subsurface lesions in bovine enamelHendrik Meyer-Lueckel, Sebastian Paris, Jan Mueller, et al.Lung Cancer (Amsterdam, Netherlands)|August 11, 2004
Targeted radiotherapy for small cell lung cancer using 90Yttrium-DOTATOC, an Yttrium-labelled somatostatin analogue: a pilot trialMiklos Pless, Christian Waldherr, Helmut Maecke, et al.Journal of Molecular Biology|March 31, 2012
Direct determination of actin polarity in the cellAkihiro Narita, Jan Mueller, Edit Urban, et al.International Journal of Cancer|July 2, 2009
Endogenous expression of the sodium iodide symporter mediates uptake of iodide in murine models of colorectal carcinomaFlorian C Gaertner, Franziska Rohde, Jan Mueller, et al.Blood|May 26, 2010
PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cellsRavikumar Muthuswamy, Jan Mueller-Berghaus, Uwe Haberkorn, et al.Current Oncology (Toronto, Ont.)|October 25, 2024
Comparative Efficacy and Safety of Neoadjuvant Immunotherapy with Nivolumab vs. Pembrolizumab in Resectable Non-Small Cell Lung Cancer: A Systematic ReviewAnastasia Papaporfyriou, Konstantinos Bartziokas, Ioulianos Apessos, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 22, 2015
90Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive MeningiomasKarine Gerster-Gilliéron, Flavio Forrer, Helmut Maecke, et al.British Journal of Pharmacology|July 22, 2014
Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signallingAnita Pathil, Jan Mueller, Johannes M Ludwig, et al.Pageof 7